| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -15 | 88 | 1.38 | 0.30 | BLENDED GS |
| May 2025 | 37 | 88 | -1.31 | 1.64 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -15 | 88 | 1.38 | 0.30 | BLENDED GS |
| May 2025 | 37 | 88 | -1.31 | 1.64 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 317 | 104 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 126 | 404 | 6225 | 384 | 388 | 87 | 86 |
| May 2025 | 121 | 384 | 5653 | 384 | 386 | 90 | 87 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 126 | 404 | 6225 | 384 | 388 | 87 | 86 |
| May 2025 | 121 | 384 | 5653 | 384 | 386 | 90 | 87 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 398 | 244 | 89 | 12 | |
| No. Herds | 121 | 104 | 54 | 10 | |
| No. without completed record | 37 | 117 | 130 | 67 | 12 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 398 | 244 | 89 | 12 | |
| No. Herds | 121 | 104 | 54 | 10 | |
| No. without completed record | 37 | 117 | 130 | 67 | 12 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 317 | 104 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 23 | 13 | 0 | 0 |
| DFS | 60 | 21 | 66 | 19 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 0 | 0 | 0 | 0 |
| GER | 136 | 47 | 200 | 51 |
| ITA | 0 | 0 | 0 | 0 |
| NLD | 925 | 362 | 950 | 379 |
| NZL | 1365 | 156 | 635 | 84 |
| USA | 0 | 0 | 83 | 39 |